The maximum Bi-Est dosage specified in the Initial Dosing Procedure Cards (example: “Most Common Starting Rx”), is:

This total daily maximum number of drops of Bi-Est (see question 1 above) equals a strength of:

> 95% of all patients you consult with in perimenopause will do well with an initial Bi-Est Rx of 30 mg/ml 80:20 as well as an Rx of progesterone 200 mg/ml.

One drop of Bi-Est 30 mg/ml 80:20 in the patent-pending Menopause Method bottles with orifice reducers has a potency of:

Clinically, dose determination should result in which of the following?

Clinically, dose determination should result in which of the following?

If a patient still has concerns after the review of the subject of risks in the first consultation